Nipro Corporation

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SRTOY has a market cap of 189.7B. Regarding current trading prices, NPRRF is priced at $9.96, while SRTOY trades at $19.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SRTOY's P/E ratio is 60.94. In terms of profitability, NPRRF's ROE is N/A, compared to SRTOY's ROE of +0.06%. Regarding short-term risk, NPRRF is more volatile compared to SRTOY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check SRTOY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, ESLOY has a market cap of 97.6B. Regarding current trading prices, NPRRF is priced at $9.96, while ESLOY trades at $107.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas ESLOY's P/E ratio is 36.50. In terms of profitability, NPRRF's ROE is N/A, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, NPRRF is more volatile compared to ESLOY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check ESLOY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, ESLOF has a market cap of 95.4B. Regarding current trading prices, NPRRF is priced at $9.96, while ESLOF trades at $209.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas ESLOF's P/E ratio is 35.33. In terms of profitability, NPRRF's ROE is N/A, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, NPRRF is less volatile compared to ESLOF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check ESLOF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SOAGY has a market cap of 77.6B. Regarding current trading prices, NPRRF is priced at $9.96, while SOAGY trades at $52.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SOAGY's P/E ratio is 96.55. In terms of profitability, NPRRF's ROE is N/A, compared to SOAGY's ROE of +0.06%. Regarding short-term risk, NPRRF is more volatile compared to SOAGY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check SOAGY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, HOCPF has a market cap of 63.8B. Regarding current trading prices, NPRRF is priced at $9.96, while HOCPF trades at $190.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas HOCPF's P/E ratio is 40.81. In terms of profitability, NPRRF's ROE is N/A, compared to HOCPF's ROE of +0.25%. Regarding short-term risk, NPRRF is more volatile compared to HOCPF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check HOCPF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, HOCPY has a market cap of 62B. Regarding current trading prices, NPRRF is priced at $9.96, while HOCPY trades at $174.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas HOCPY's P/E ratio is 39.67. In terms of profitability, NPRRF's ROE is N/A, compared to HOCPY's ROE of +0.25%. Regarding short-term risk, NPRRF is more volatile compared to HOCPY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check HOCPY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, RSMDF has a market cap of 36.3B. Regarding current trading prices, NPRRF is priced at $9.96, while RSMDF trades at $24.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas RSMDF's P/E ratio is 23.93. In terms of profitability, NPRRF's ROE is N/A, compared to RSMDF's ROE of +0.24%. Regarding short-term risk, NPRRF is less volatile compared to RSMDF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check RSMDF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, MECNY has a market cap of 26.9B. Regarding current trading prices, NPRRF is priced at $9.96, while MECNY trades at $88.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas MECNY's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to MECNY's ROE of +0.02%. Regarding short-term risk, NPRRF is more volatile compared to MECNY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check MECNY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, TRUMF has a market cap of 19.8B. Regarding current trading prices, NPRRF is priced at $9.96, while TRUMF trades at $13.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas TRUMF's P/E ratio is 24.45. In terms of profitability, NPRRF's ROE is N/A, compared to TRUMF's ROE of +0.09%. Regarding short-term risk, NPRRF is more volatile compared to TRUMF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check TRUMF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, TRUMY has a market cap of 19B. Regarding current trading prices, NPRRF is priced at $9.96, while TRUMY trades at $12.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas TRUMY's P/E ratio is 22.98. In terms of profitability, NPRRF's ROE is N/A, compared to TRUMY's ROE of +0.09%. Regarding short-term risk, NPRRF is more volatile compared to TRUMY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check TRUMY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SDMHF has a market cap of 18.5B. Regarding current trading prices, NPRRF is priced at $9.96, while SDMHF trades at $196.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SDMHF's P/E ratio is 58.64. In terms of profitability, NPRRF's ROE is N/A, compared to SDMHF's ROE of +0.07%. Regarding short-term risk, NPRRF is more volatile compared to SDMHF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check SDMHF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SAUHY has a market cap of 18B. Regarding current trading prices, NPRRF is priced at $9.96, while SAUHY trades at $10.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SAUHY's P/E ratio is 40.32. In terms of profitability, NPRRF's ROE is N/A, compared to SAUHY's ROE of +0.17%. Regarding short-term risk, NPRRF is less volatile compared to SAUHY. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check SAUHY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SAUHF has a market cap of 17.5B. Regarding current trading prices, NPRRF is priced at $9.96, while SAUHF trades at $109.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SAUHF's P/E ratio is 38.41. In terms of profitability, NPRRF's ROE is N/A, compared to SAUHF's ROE of +0.17%. Regarding short-term risk, NPRRF is more volatile compared to SAUHF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check SAUHF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SUVPF has a market cap of 17.3B. Regarding current trading prices, NPRRF is priced at $9.96, while SUVPF trades at $250.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SUVPF's P/E ratio is 91.24. In terms of profitability, NPRRF's ROE is N/A, compared to SUVPF's ROE of +0.06%. Regarding short-term risk, NPRRF is less volatile compared to SUVPF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check SUVPF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SSSGY has a market cap of 14.9B. Regarding current trading prices, NPRRF is priced at $9.96, while SSSGY trades at $43.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SSSGY's P/E ratio is 78.54. In terms of profitability, NPRRF's ROE is N/A, compared to SSSGY's ROE of +0.06%. Regarding short-term risk, NPRRF is less volatile compared to SSSGY. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check SSSGY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SARTF has a market cap of 14.7B. Regarding current trading prices, NPRRF is priced at $9.96, while SARTF trades at $212.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SARTF's P/E ratio is 76.94. In terms of profitability, NPRRF's ROE is N/A, compared to SARTF's ROE of +0.06%. Regarding short-term risk, NPRRF is more volatile compared to SARTF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check SARTF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, CLPBY has a market cap of 14.4B. Regarding current trading prices, NPRRF is priced at $9.96, while CLPBY trades at $6.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas CLPBY's P/E ratio is 22.82. In terms of profitability, NPRRF's ROE is N/A, compared to CLPBY's ROE of +0.25%. Regarding short-term risk, NPRRF is more volatile compared to CLPBY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check CLPBY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, FSPKF has a market cap of 13.5B. Regarding current trading prices, NPRRF is priced at $9.96, while FSPKF trades at $23.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas FSPKF's P/E ratio is 52.32. In terms of profitability, NPRRF's ROE is N/A, compared to FSPKF's ROE of +0.30%. Regarding short-term risk, NPRRF is more volatile compared to FSPKF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check FSPKF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, CLPBF has a market cap of 13.4B. Regarding current trading prices, NPRRF is priced at $9.96, while CLPBF trades at $64.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas CLPBF's P/E ratio is 23.28. In terms of profitability, NPRRF's ROE is N/A, compared to CLPBF's ROE of +0.25%. Regarding short-term risk, NPRRF is more volatile compared to CLPBF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check CLPBF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, OCPNF has a market cap of 10.4B. Regarding current trading prices, NPRRF is priced at $9.96, while OCPNF trades at $9.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas OCPNF's P/E ratio is 17.57. In terms of profitability, NPRRF's ROE is N/A, compared to OCPNF's ROE of +0.11%. Regarding short-term risk, NPRRF is more volatile compared to OCPNF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check OCPNF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, CNVVF has a market cap of 5.8B. Regarding current trading prices, NPRRF is priced at $9.96, while CNVVF trades at $2.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas CNVVF's P/E ratio is 33.22. In terms of profitability, NPRRF's ROE is N/A, compared to CNVVF's ROE of +0.11%. Regarding short-term risk, NPRRF is less volatile compared to CNVVF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check CNVVF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, AHICF has a market cap of 5.7B. Regarding current trading prices, NPRRF is priced at $9.96, while AHICF trades at $21.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas AHICF's P/E ratio is 51.48. In terms of profitability, NPRRF's ROE is N/A, compared to AHICF's ROE of +0.12%. Regarding short-term risk, NPRRF is less volatile compared to AHICF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check AHICF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, CNVVY has a market cap of 5.7B. Regarding current trading prices, NPRRF is priced at $9.96, while CNVVY trades at $11.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas CNVVY's P/E ratio is 34.47. In terms of profitability, NPRRF's ROE is N/A, compared to CNVVY's ROE of +0.10%. Regarding short-term risk, NPRRF is more volatile compared to CNVVY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check CNVVY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SSMXY has a market cap of 5.3B. Regarding current trading prices, NPRRF is priced at $9.96, while SSMXY trades at $8.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SSMXY's P/E ratio is 18.19. In terms of profitability, NPRRF's ROE is N/A, compared to SSMXY's ROE of +0.09%. Regarding short-term risk, NPRRF is more volatile compared to SSMXY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check SSMXY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SSMXF has a market cap of 5.3B. Regarding current trading prices, NPRRF is priced at $9.96, while SSMXF trades at $8.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SSMXF's P/E ratio is 17.94. In terms of profitability, NPRRF's ROE is N/A, compared to SSMXF's ROE of +0.09%. Regarding short-term risk, NPRRF is less volatile compared to SSMXF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check SSMXF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, ADDLF has a market cap of 4.9B. Regarding current trading prices, NPRRF is priced at $9.96, while ADDLF trades at $42.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, NPRRF's ROE is N/A, compared to ADDLF's ROE of +0.11%. Regarding short-term risk, NPRRF is more volatile compared to ADDLF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check ADDLF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, YPHDF has a market cap of 4.8B. Regarding current trading prices, NPRRF is priced at $9.96, while YPHDF trades at $354.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas YPHDF's P/E ratio is 19.73. In terms of profitability, NPRRF's ROE is N/A, compared to YPHDF's ROE of +0.27%. Regarding short-term risk, NPRRF is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check YPHDF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, FLMNF has a market cap of 4.3B. Regarding current trading prices, NPRRF is priced at $9.96, while FLMNF trades at $50.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas FLMNF's P/E ratio is 19.98. In terms of profitability, NPRRF's ROE is N/A, compared to FLMNF's ROE of +0.22%. Regarding short-term risk, NPRRF is less volatile compared to FLMNF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check FLMNF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, FLMNY has a market cap of 4.2B. Regarding current trading prices, NPRRF is priced at $9.96, while FLMNY trades at $9.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas FLMNY's P/E ratio is 19.48. In terms of profitability, NPRRF's ROE is N/A, compared to FLMNY's ROE of +0.21%. Regarding short-term risk, NPRRF is more volatile compared to FLMNY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check FLMNY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, ANSLF has a market cap of 3.2B. Regarding current trading prices, NPRRF is priced at $9.96, while ANSLF trades at $22.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas ANSLF's P/E ratio is 32.49. In terms of profitability, NPRRF's ROE is N/A, compared to ANSLF's ROE of +0.07%. Regarding short-term risk, NPRRF is more volatile compared to ANSLF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check ANSLF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, ANSLY has a market cap of 3B. Regarding current trading prices, NPRRF is priced at $9.96, while ANSLY trades at $78.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas ANSLY's P/E ratio is 22.45. In terms of profitability, NPRRF's ROE is N/A, compared to ANSLY's ROE of +0.07%. Regarding short-term risk, NPRRF is more volatile compared to ANSLY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check ANSLY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, CZMWY has a market cap of 2.7B. Regarding current trading prices, NPRRF is priced at $9.96, while CZMWY trades at $30.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas CZMWY's P/E ratio is 16.22. In terms of profitability, NPRRF's ROE is N/A, compared to CZMWY's ROE of +0.06%. Regarding short-term risk, NPRRF is more volatile compared to CZMWY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check CZMWY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, CZMWF has a market cap of 2.7B. Regarding current trading prices, NPRRF is priced at $9.96, while CZMWF trades at $30.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas CZMWF's P/E ratio is 16.12. In terms of profitability, NPRRF's ROE is N/A, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, NPRRF is less volatile compared to CZMWF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check CZMWF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, EKTAY has a market cap of 2.3B. Regarding current trading prices, NPRRF is priced at $9.96, while EKTAY trades at $5.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas EKTAY's P/E ratio is -597.00. In terms of profitability, NPRRF's ROE is N/A, compared to EKTAY's ROE of -0.00%. Regarding short-term risk, NPRRF is more volatile compared to EKTAY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check EKTAY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, TCGGY has a market cap of 2.3B. Regarding current trading prices, NPRRF is priced at $9.96, while TCGGY trades at $36.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas TCGGY's P/E ratio is 27.27. In terms of profitability, NPRRF's ROE is N/A, compared to TCGGY's ROE of -0.09%. Regarding short-term risk, NPRRF is less volatile compared to TCGGY. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check TCGGY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, EKTAF has a market cap of 2.2B. Regarding current trading prices, NPRRF is priced at $9.96, while EKTAF trades at $6.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas EKTAF's P/E ratio is -606.00. In terms of profitability, NPRRF's ROE is N/A, compared to EKTAF's ROE of -0.00%. Regarding short-term risk, NPRRF is more volatile compared to EKTAF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check EKTAF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, TCHBF has a market cap of 2.2B. Regarding current trading prices, NPRRF is priced at $9.96, while TCHBF trades at $175.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas TCHBF's P/E ratio is -15.88. In terms of profitability, NPRRF's ROE is N/A, compared to TCHBF's ROE of -0.09%. Regarding short-term risk, NPRRF is less volatile compared to TCHBF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check TCHBF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SHWGY has a market cap of 2B. Regarding current trading prices, NPRRF is priced at $9.96, while SHWGY trades at $1.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SHWGY's P/E ratio is 8.75. In terms of profitability, NPRRF's ROE is N/A, compared to SHWGY's ROE of +0.07%. Regarding short-term risk, NPRRF is less volatile compared to SHWGY. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check SHWGY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SHWGF has a market cap of 2B. Regarding current trading prices, NPRRF is priced at $9.96, while SHWGF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SHWGF's P/E ratio is 8.80. In terms of profitability, NPRRF's ROE is N/A, compared to SHWGF's ROE of +0.07%. Regarding short-term risk, NPRRF is less volatile compared to SHWGF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check SHWGF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, BOEUF has a market cap of 1.6B. Regarding current trading prices, NPRRF is priced at $9.96, while BOEUF trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas BOEUF's P/E ratio is 81.73. In terms of profitability, NPRRF's ROE is N/A, compared to BOEUF's ROE of +0.22%. Regarding short-term risk, NPRRF is more volatile compared to BOEUF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check BOEUF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, TGLVY has a market cap of 1.2B. Regarding current trading prices, NPRRF is priced at $9.96, while TGLVY trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas TGLVY's P/E ratio is 31.05. In terms of profitability, NPRRF's ROE is N/A, compared to TGLVY's ROE of +0.03%. Regarding short-term risk, NPRRF is more volatile compared to TGLVY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check TGLVY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SAFLY has a market cap of 1.2B. Regarding current trading prices, NPRRF is priced at $9.96, while SAFLY trades at $4.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SAFLY's P/E ratio is 14.81. In terms of profitability, NPRRF's ROE is N/A, compared to SAFLY's ROE of +0.12%. Regarding short-term risk, NPRRF is less volatile compared to SAFLY. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check SAFLY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, BITGF has a market cap of 1.2B. Regarding current trading prices, NPRRF is priced at $9.96, while BITGF trades at $15.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas BITGF's P/E ratio is 45.50. In terms of profitability, NPRRF's ROE is N/A, compared to BITGF's ROE of +0.04%. Regarding short-term risk, NPRRF is more volatile compared to BITGF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check BITGF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, PBHDF has a market cap of 1.2B. Regarding current trading prices, NPRRF is priced at $9.96, while PBHDF trades at $19.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, NPRRF's ROE is N/A, compared to PBHDF's ROE of +0.07%. Regarding short-term risk, NPRRF is more volatile compared to PBHDF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check PBHDF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, TDVXF has a market cap of 936.7M. Regarding current trading prices, NPRRF is priced at $9.96, while TDVXF trades at $8.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas TDVXF's P/E ratio is 49.30. In terms of profitability, NPRRF's ROE is N/A, compared to TDVXF's ROE of +0.32%. Regarding short-term risk, NPRRF is less volatile compared to TDVXF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check TDVXF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SAFLF has a market cap of 906.6M. Regarding current trading prices, NPRRF is priced at $9.96, while SAFLF trades at $2.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SAFLF's P/E ratio is 16.50. In terms of profitability, NPRRF's ROE is N/A, compared to SAFLF's ROE of +0.12%. Regarding short-term risk, NPRRF is more volatile compared to SAFLF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check SAFLF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, KSRBF has a market cap of 841.7M. Regarding current trading prices, NPRRF is priced at $9.96, while KSRBF trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas KSRBF's P/E ratio is 33.29. In terms of profitability, NPRRF's ROE is N/A, compared to KSRBF's ROE of +0.04%. Regarding short-term risk, NPRRF is more volatile compared to KSRBF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check KSRBF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, HGYMF has a market cap of 754.4M. Regarding current trading prices, NPRRF is priced at $9.96, while HGYMF trades at $34.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas HGYMF's P/E ratio is 184.16. In terms of profitability, NPRRF's ROE is N/A, compared to HGYMF's ROE of +0.00%. Regarding short-term risk, NPRRF is more volatile compared to HGYMF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check HGYMF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, GRRMF has a market cap of 713.3M. Regarding current trading prices, NPRRF is priced at $9.96, while GRRMF trades at $31.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas GRRMF's P/E ratio is 25.81. In terms of profitability, NPRRF's ROE is N/A, compared to GRRMF's ROE of +0.02%. Regarding short-term risk, NPRRF is more volatile compared to GRRMF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check GRRMF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, NNCSF has a market cap of 706.4M. Regarding current trading prices, NPRRF is priced at $9.96, while NNCSF trades at $2.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas NNCSF's P/E ratio is 47.28. In terms of profitability, NPRRF's ROE is N/A, compared to NNCSF's ROE of +0.10%. Regarding short-term risk, NPRRF is more volatile compared to NNCSF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check NNCSF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, JNDOF has a market cap of 531.1M. Regarding current trading prices, NPRRF is priced at $9.96, while JNDOF trades at $22.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, NPRRF's ROE is N/A, compared to JNDOF's ROE of +0.27%. Regarding short-term risk, NPRRF is more volatile compared to JNDOF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check JNDOF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SPMXF has a market cap of 458.6M. Regarding current trading prices, NPRRF is priced at $9.96, while SPMXF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SPMXF's P/E ratio is -15.00. In terms of profitability, NPRRF's ROE is N/A, compared to SPMXF's ROE of -0.07%. Regarding short-term risk, NPRRF is less volatile compared to SPMXF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check SPMXF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, CLHLF has a market cap of 365.5M. Regarding current trading prices, NPRRF is priced at $9.96, while CLHLF trades at $61.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas CLHLF's P/E ratio is 27.93. In terms of profitability, NPRRF's ROE is N/A, compared to CLHLF's ROE of +0.16%. Regarding short-term risk, NPRRF is more volatile compared to CLHLF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check CLHLF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, NPRRF is priced at $9.96, while GUERF trades at $22.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas GUERF's P/E ratio is 8.19. In terms of profitability, NPRRF's ROE is N/A, compared to GUERF's ROE of +0.04%. Regarding short-term risk, NPRRF is more volatile compared to GUERF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check GUERF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, TSNLF has a market cap of 265.1M. Regarding current trading prices, NPRRF is priced at $9.96, while TSNLF trades at $5.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas TSNLF's P/E ratio is 25.14. In terms of profitability, NPRRF's ROE is N/A, compared to TSNLF's ROE of +0.24%. Regarding short-term risk, NPRRF is less volatile compared to TSNLF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check TSNLF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, OPSSF has a market cap of 247.4M. Regarding current trading prices, NPRRF is priced at $9.96, while OPSSF trades at $2.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, NPRRF's ROE is N/A, compared to OPSSF's ROE of -0.36%. Regarding short-term risk, NPRRF is more volatile compared to OPSSF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check OPSSF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, EEOIF has a market cap of 63.4M. Regarding current trading prices, NPRRF is priced at $9.96, while EEOIF trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, NPRRF's ROE is N/A, compared to EEOIF's ROE of N/A. Regarding short-term risk, NPRRF is more volatile compared to EEOIF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check EEOIF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, OTCFF has a market cap of 21.4M. Regarding current trading prices, NPRRF is priced at $9.96, while OTCFF trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas OTCFF's P/E ratio is -13.33. In terms of profitability, NPRRF's ROE is N/A, compared to OTCFF's ROE of +1.38%. Regarding short-term risk, NPRRF is more volatile compared to OTCFF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check OTCFF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, UEEC has a market cap of 18.1M. Regarding current trading prices, NPRRF is priced at $9.96, while UEEC trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas UEEC's P/E ratio is -7.00. In terms of profitability, NPRRF's ROE is N/A, compared to UEEC's ROE of +0.81%. Regarding short-term risk, NPRRF is more volatile compared to UEEC. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check UEEC's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, TUTH has a market cap of 5.5M. Regarding current trading prices, NPRRF is priced at $9.96, while TUTH trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas TUTH's P/E ratio is -2.18. In terms of profitability, NPRRF's ROE is N/A, compared to TUTH's ROE of +0.27%. Regarding short-term risk, NPRRF is less volatile compared to TUTH. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check TUTH's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, BLMHF has a market cap of 5.2M. Regarding current trading prices, NPRRF is priced at $9.96, while BLMHF trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, NPRRF's ROE is N/A, compared to BLMHF's ROE of N/A. Regarding short-term risk, NPRRF is more volatile compared to BLMHF. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check BLMHF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, PXMVF has a market cap of 4.6M. Regarding current trading prices, NPRRF is priced at $9.96, while PXMVF trades at $1.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, NPRRF's ROE is N/A, compared to PXMVF's ROE of -6.46%. Regarding short-term risk, NPRRF is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check PXMVF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, CBSC has a market cap of 4.5M. Regarding current trading prices, NPRRF is priced at $9.96, while CBSC trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas CBSC's P/E ratio is -4.00. In terms of profitability, NPRRF's ROE is N/A, compared to CBSC's ROE of +0.58%. Regarding short-term risk, NPRRF is more volatile compared to CBSC. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check CBSC's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, MCDA has a market cap of 4.2M. Regarding current trading prices, NPRRF is priced at $9.96, while MCDA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas MCDA's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to MCDA's ROE of N/A. Regarding short-term risk, NPRRF is more volatile compared to MCDA. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check MCDA's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, GVDI has a market cap of 4.2M. Regarding current trading prices, NPRRF is priced at $9.96, while GVDI trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas GVDI's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to GVDI's ROE of +0.00%. Regarding short-term risk, NPRRF is more volatile compared to GVDI. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check GVDI's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, RSCF has a market cap of 3.6M. Regarding current trading prices, NPRRF is priced at $9.96, while RSCF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas RSCF's P/E ratio is -4.20. In terms of profitability, NPRRF's ROE is N/A, compared to RSCF's ROE of +0.10%. Regarding short-term risk, NPRRF is less volatile compared to RSCF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check RSCF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, NSTGQ has a market cap of 3.3M. Regarding current trading prices, NPRRF is priced at $9.96, while NSTGQ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to NSTGQ's ROE of N/A. Regarding short-term risk, NPRRF is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check NSTGQ's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, ECIA has a market cap of 2.5M. Regarding current trading prices, NPRRF is priced at $9.96, while ECIA trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas ECIA's P/E ratio is -6.67. In terms of profitability, NPRRF's ROE is N/A, compared to ECIA's ROE of -0.22%. Regarding short-term risk, NPRRF is more volatile compared to ECIA. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check ECIA's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, YBGJ has a market cap of 1M. Regarding current trading prices, NPRRF is priced at $9.96, while YBGJ trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas YBGJ's P/E ratio is -0.84. In terms of profitability, NPRRF's ROE is N/A, compared to YBGJ's ROE of +0.38%. Regarding short-term risk, NPRRF is more volatile compared to YBGJ. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check YBGJ's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, OJSY has a market cap of 454.3K. Regarding current trading prices, NPRRF is priced at $9.96, while OJSY trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas OJSY's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to OJSY's ROE of N/A. Regarding short-term risk, NPRRF is more volatile compared to OJSY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check OJSY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, PDMI has a market cap of 324.9K. Regarding current trading prices, NPRRF is priced at $9.96, while PDMI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas PDMI's P/E ratio is -0.01. In terms of profitability, NPRRF's ROE is N/A, compared to PDMI's ROE of +0.19%. Regarding short-term risk, NPRRF is more volatile compared to PDMI. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check PDMI's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, WHSI has a market cap of 182.7K. Regarding current trading prices, NPRRF is priced at $9.96, while WHSI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas WHSI's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to WHSI's ROE of +0.84%. Regarding short-term risk, NPRRF is more volatile compared to WHSI. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check WHSI's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, BLFE has a market cap of 156.7K. Regarding current trading prices, NPRRF is priced at $9.96, while BLFE trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas BLFE's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to BLFE's ROE of +3.67%. Regarding short-term risk, NPRRF is more volatile compared to BLFE. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check BLFE's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, QTXB has a market cap of 118K. Regarding current trading prices, NPRRF is priced at $9.96, while QTXB trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas QTXB's P/E ratio is -0.05. In terms of profitability, NPRRF's ROE is N/A, compared to QTXB's ROE of +0.19%. Regarding short-term risk, NPRRF is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check QTXB's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, CEOS has a market cap of 107.7K. Regarding current trading prices, NPRRF is priced at $9.96, while CEOS trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas CEOS's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to CEOS's ROE of +7.33%. Regarding short-term risk, NPRRF is more volatile compared to CEOS. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check CEOS's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, IMTH has a market cap of 101.7K. Regarding current trading prices, NPRRF is priced at $9.96, while IMTH trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas IMTH's P/E ratio is -0.03. In terms of profitability, NPRRF's ROE is N/A, compared to IMTH's ROE of -0.60%. Regarding short-term risk, NPRRF is less volatile compared to IMTH. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check IMTH's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, LANZ has a market cap of 74.5K. Regarding current trading prices, NPRRF is priced at $9.96, while LANZ trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas LANZ's P/E ratio is 2.70. In terms of profitability, NPRRF's ROE is N/A, compared to LANZ's ROE of +0.01%. Regarding short-term risk, NPRRF is less volatile compared to LANZ. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check LANZ's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, GMVDF has a market cap of 52K. Regarding current trading prices, NPRRF is priced at $9.96, while GMVDF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas GMVDF's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to GMVDF's ROE of +3.68%. Regarding short-term risk, NPRRF is less volatile compared to GMVDF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check GMVDF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, REMI has a market cap of 14K. Regarding current trading prices, NPRRF is priced at $9.96, while REMI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas REMI's P/E ratio is -0.07. In terms of profitability, NPRRF's ROE is N/A, compared to REMI's ROE of -0.11%. Regarding short-term risk, NPRRF is less volatile compared to REMI. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check REMI's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, MDIT has a market cap of 8.7K. Regarding current trading prices, NPRRF is priced at $9.96, while MDIT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas MDIT's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to MDIT's ROE of -0.99%. Regarding short-term risk, NPRRF is more volatile compared to MDIT. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check MDIT's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, ASFX has a market cap of 5.3K. Regarding current trading prices, NPRRF is priced at $9.96, while ASFX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas ASFX's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to ASFX's ROE of +0.00%. Regarding short-term risk, NPRRF is less volatile compared to ASFX. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check ASFX's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, DGEN has a market cap of 3.9K. Regarding current trading prices, NPRRF is priced at $9.96, while DGEN trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas DGEN's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to DGEN's ROE of +0.05%. Regarding short-term risk, NPRRF is more volatile compared to DGEN. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check DGEN's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SVSO has a market cap of 2.6K. Regarding current trading prices, NPRRF is priced at $9.96, while SVSO trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SVSO's P/E ratio is -0.01. In terms of profitability, NPRRF's ROE is N/A, compared to SVSO's ROE of +0.17%. Regarding short-term risk, NPRRF is more volatile compared to SVSO. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check SVSO's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, LFPI has a market cap of 2.1K. Regarding current trading prices, NPRRF is priced at $9.96, while LFPI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas LFPI's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to LFPI's ROE of -4.85%. Regarding short-term risk, NPRRF is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check LFPI's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SDCCQ has a market cap of 1.3K. Regarding current trading prices, NPRRF is priced at $9.96, while SDCCQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, NPRRF is less volatile compared to SDCCQ. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check SDCCQ's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, INND has a market cap of 1.2K. Regarding current trading prices, NPRRF is priced at $9.96, while INND trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas INND's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to INND's ROE of -0.01%. Regarding short-term risk, NPRRF is more volatile compared to INND. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check INND's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SEYE has a market cap of 1.2K. Regarding current trading prices, NPRRF is priced at $9.96, while SEYE trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SEYE's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to SEYE's ROE of N/A. Regarding short-term risk, NPRRF is more volatile compared to SEYE. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check SEYE's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, BGMD has a market cap of 1.1K. Regarding current trading prices, NPRRF is priced at $9.96, while BGMD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas BGMD's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to BGMD's ROE of +7.47%. Regarding short-term risk, NPRRF is more volatile compared to BGMD. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check BGMD's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, ADLI has a market cap of 1K. Regarding current trading prices, NPRRF is priced at $9.96, while ADLI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas ADLI's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to ADLI's ROE of +1.36%. Regarding short-term risk, NPRRF is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check ADLI's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, VSMD has a market cap of 802. Regarding current trading prices, NPRRF is priced at $9.96, while VSMD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas VSMD's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to VSMD's ROE of +3.15%. Regarding short-term risk, NPRRF is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check VSMD's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, TEVNF has a market cap of 744. Regarding current trading prices, NPRRF is priced at $9.96, while TEVNF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas TEVNF's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, NPRRF is less volatile compared to TEVNF. This indicates potentially lower risk in terms of short-term price fluctuations for NPRRF.Check TEVNF's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, HRAL has a market cap of 396. Regarding current trading prices, NPRRF is priced at $9.96, while HRAL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas HRAL's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to HRAL's ROE of +0.21%. Regarding short-term risk, NPRRF is more volatile compared to HRAL. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check HRAL's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, MICRD has a market cap of 317. Regarding current trading prices, NPRRF is priced at $9.96, while MICRD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas MICRD's P/E ratio is -0.00. In terms of profitability, NPRRF's ROE is N/A, compared to MICRD's ROE of -0.25%. Regarding short-term risk, NPRRF is more volatile compared to MICRD. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check MICRD's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, RGBOQ has a market cap of 97. Regarding current trading prices, NPRRF is priced at $9.96, while RGBOQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, NPRRF's ROE is N/A, compared to RGBOQ's ROE of N/A. Regarding short-term risk, NPRRF is more volatile compared to RGBOQ. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check RGBOQ's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, SECI has a market cap of 31. Regarding current trading prices, NPRRF is priced at $9.96, while SECI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas SECI's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to SECI's ROE of -0.00%. Regarding short-term risk, NPRRF is more volatile compared to SECI. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check SECI's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, VTEQ has a market cap of 1. Regarding current trading prices, NPRRF is priced at $9.96, while VTEQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, NPRRF's ROE is N/A, compared to VTEQ's ROE of N/A. Regarding short-term risk, NPRRF is more volatile compared to VTEQ. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check VTEQ's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, OCPNY has a market cap of 0. Regarding current trading prices, NPRRF is priced at $9.96, while OCPNY trades at $18.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas OCPNY's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to OCPNY's ROE of +0.26%. Regarding short-term risk, NPRRF is more volatile compared to OCPNY. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check OCPNY's competition here

NPRRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NPRRF stands at 1.6B. In comparison, MEDVD has a market cap of 0. Regarding current trading prices, NPRRF is priced at $9.96, while MEDVD trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NPRRF currently has a P/E ratio of 26.21, whereas MEDVD's P/E ratio is N/A. In terms of profitability, NPRRF's ROE is N/A, compared to MEDVD's ROE of N/A. Regarding short-term risk, NPRRF is more volatile compared to MEDVD. This indicates potentially higher risk in terms of short-term price fluctuations for NPRRF.Check MEDVD's competition here